BamSEC and AlphaSense Join Forces
Learn More

CTI BioPharma Corp

Formerly NASDAQ: CTIC

Indentures Filter

EX-4.4
from 10-K 2 pages Description of Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.4
from 10-K 2 pages Description of Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from S-8 52 pages Amended and Restated Certificate of Incorporation of CTI BioPharma Corp
12/34/56
EX-4.5
from 10-K 2 pages Description of Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.6
from 10-K 2 pages Description of Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.5
from 10-K 9 pages Warrant to Purchase Stock
12/34/56
EX-4.1
from 8-K 3 pages Indenture or similar
12/34/56
EX-4.2
from 8-K 11 pages Warrant to Purchase Stock
12/34/56
EX-4.1
from 8-K 11 pages Warrant to Purchase Stock
12/34/56
EX-4.1
from 8-K 3 pages Fourth Amendment to Shareholder Rights Agreement
12/34/56
EX-4.1
from 8-A12G/A 3 pages Fourth Amendment to Shareholder Rights Agreement
12/34/56
EX-4.1
from 8-K 3 pages Third Amendment to Shareholder Rights Agreement
12/34/56
EX-4.1
from S-8 14 pages CTI BioPharma Corp. 2015 Equity Incentive Plan
12/34/56
EX-4.1
from 8-K 17 pages Warrant Agreement to Purchase Shares of the Common Stock of CTI BioPharma Corp. Dated as of June 9, 2015
12/34/56
EX-4.12
from S-3 52 pages CTI BioPharma Corp. Issuer and [ ] Trustee Indenture Dated as of [ ] Subordinated Debt Securities
12/34/56
EX-4.11
from S-3 52 pages CTI BioPharma Corp. Issuer and [ ] Trustee Indenture Dated as of [ ] Senior Debt Securities
12/34/56
EX-4.3
from S-3 2 pages 016570| 003590|127c|restricted||4|057-423 Common Stock No Par Value Common Stock This Certificate Is Transferable in Canton, Ma and New York, Ny Certificate Number Zq 000000 Cti Biopharma Corp. Incorporated Under the Laws of the State of Washington This Certifies That Mr. Sample & Mrs. Sample & Mr. Sample & Mrs. Sample Cusip 12648l 10 6 See Reverse for Certain Definitions Shares * * 000000 * * * * * * * * * 000000 * * * * * * * * * 000000 * * * * * * * * * 000000* * * * * * * * * 000000* * Is the Owner of ***Zero Hundred Thousand Zero Hundred and Zero*** Fully-Paid and Non-Assessable Shares of Common Stock, No Par Value, of Cti Biopharma Corp. (Hereinafter Called the “Corporation”), Transferable Only on the Books of the Corporation by the Holder Hereof in Person or by Duly Authorized Attorney, Upon Surrender of This Certificate Properly Endorsed. This Certificate Is Not Valid Until Countersigned and Registered by the Transfer Agent and Registrar. in Witness Whereof, the Said Corporation Has Caused This Certificate to Be Signed by Its Duly Authorized Officers and to Be Sealed With the Seal of the Corporation. President and Chief Executive Officer Executive Vice President, Finance and Administration Cti Biopharma Corp. Corporate 1991 Seal Washington Dated <<month Day, Year>> Countersigned and Registered: Computershare Trust Company, N.A. Transfer Agent and Registrar, by Authorized Signature Security Instructions on Reverse Cti Biopharma Corp. Po Box 43004, Providence, Ri 02940-3004 Mr a Sample Designation (If Any) Add 1 Add 2 Add 3 Add 4 Cusip Holder Id Insurance Value Number of Shares Dtc Certificate Numbers 1234567890/1234567890 1234567890/1234567890 1234567890/1234567890 1234567890/1234567890 1234567890/ 1234567890 1234567890/1234567890 Total Transaction 12648l 10 6 Xxxxxxxxxx 1,000,000.00 123456 12345678 123456789012345 Num/No. Denom. Total 123456 123456 1234567 1234567 CTI BioPharma Corp
12/34/56
EX-4
from 8-K 2 pages CTI BioPharma Corp. a Washington Corporation
12/34/56
EX-4
from S-8 14 pages CTI BioPharma Corp. 2007 Equity Incentive Plan Effective as of June 20, 2003 and Amended and Restated as of May 30, 2014 Section 1 Background and Purpose Section 2 Definitions
12/34/56
EX-4.1
from 8-K 2 pages Cell Therapeutics, Inc. a Washington Corporation
12/34/56